![]() |
Canaccord Genuity analyst issues BUY recommendation for ALAR on November...
November 28, 2025 ALAR -21.62% |
| ||
| ||
| ||
|

November 28, 2025 ELBM -3.63%

November 25, 2025 FBRX -4.55%

November 24, 2025 BNTC 0.70%

November 21, 2025 SNTI 1.44%

November 21, 2025 BZFD 2.19%
| Top Gainers (%) | |||||||||||||||||||
| NMRD Nemaura Medical Inc. | 0.00
19,900.00% | ||||||||||||||||||
| BTTX Better Therapeutics, Inc. | 0.00
9,900.00% | ||||||||||||||||||
| ARDS Aridis Pharmaceuticals, I | 0.00
1,050.00% | ||||||||||||||||||
| ORGS Orgenesis Inc. | 0.75
341.18% | ||||||||||||||||||
| KTTAW Pasithea Therapeutics Cor | 0.04
196.36% | ||||||||||||||||||
| SMX SMX (Security Matters) Pu | 17.40
194.42% | ||||||||||||||||||
| LEXXW Lexaria Bioscience Corp | 0.04
86.73% | ||||||||||||||||||
| KALA KALA BIO, Inc. | 0.91
42.63% | ||||||||||||||||||

May 2, 2025 WRB-PF 0.52%

May 2, 2025 WRB-PH 0.30%

May 2, 2025 WRB-PG 0.53%

April 23, 2025 NEE-PN 0.32%

November 5, 2024 KKRS 0.14%